​

Funding Round

Series A - Leuko

Series A - Leuko

Investment Firm

Overview

Leuko Labs develops non-invasive white blood cell monitoring device.

Announced Date

Sep 23, 2022

Closed on Date

Jul 25, 2022

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

HTH

HTH

HTH is a early_stage_venture firm.

Participant Investors

4

Investor Name
Participant InvestorHTH
Participant InvestorIAG Capital Partners
Participant InvestorNina Capital
Participant InvestorMassVentures

Round Details and Background

Leuko raised $5000000 on 2022-09-23 in Series A

Leuko Labs develops non-invasive white blood cell monitoring device.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 23, 2022
Series A - Leuko
5-5.0M
Jun 30, 2022
Grant - Leuko
1-200.0K
Jun 30, 2021
Grant - Leuko
1-100.0K
Jul 23, 2024
Grant - Leuko
1-4.5M

Recent Activity

There is no recent news or activity for this profile.